|
US8153602B1
(en)
*
|
1991-11-19 |
2012-04-10 |
Isis Pharmaceuticals, Inc. |
Composition and methods for the pulmonary delivery of nucleic acids
|
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6239116B1
(en)
*
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US7935675B1
(en)
*
|
1994-07-15 |
2011-05-03 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US5646262A
(en)
|
1994-07-28 |
1997-07-08 |
Georgetown University |
Antisense oligonucleotides against hepatitis B viral replication
|
|
US6825174B2
(en)
|
1995-06-07 |
2004-11-30 |
East Carolina University |
Composition, formulations & method for prevention & treatment of diseases and conditions associated with bronchoconstriction, allergy(ies) & inflammation
|
|
US7034007B1
(en)
|
1995-06-07 |
2006-04-25 |
East Carolina University |
Low adenosine anti-sense oligonucleotide, compositions, kit & method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) & surfactant depletion
|
|
US5994315A
(en)
*
|
1995-06-07 |
1999-11-30 |
East Carolina University |
Low adenosine agent, composition, kit and method for treatment of airway disease
|
|
US6025339A
(en)
*
|
1995-06-07 |
2000-02-15 |
East Carolina University |
Composition, kit and method for treatment of disorders associated with bronchoconstriction and lung inflammation
|
|
EP1019065A4
(en)
*
|
1997-09-17 |
2002-02-20 |
Univ East Carolina |
NUCLEIC ACIDS HYBRIDIZING TO MULTIPLE TARGETS, THEIR PREPARATION, COMPOSITIONS, FORMULATION, KITS AND APPLICATIONS
|
|
AU760795B2
(en)
*
|
1998-05-14 |
2003-05-22 |
Coley Pharmaceutical Gmbh |
Methods for regulating hematopoiesis using CpG-oligonucleotides
|
|
CA2316994A1
(en)
*
|
1998-06-08 |
1999-12-16 |
Epigenesis Pharmaceuticals, Inc. |
Composition and method for prevention and treatment of cardiopulmonary and renal failure or damage associated with ischemia, endotoxin release, ards or brought about by administration of certain drugs
|
|
US6210892B1
(en)
*
|
1998-10-07 |
2001-04-03 |
Isis Pharmaceuticals, Inc. |
Alteration of cellular behavior by antisense modulation of mRNA processing
|
|
AU4031700A
(en)
*
|
1999-04-06 |
2000-11-02 |
East Carolina University |
Low adenosine anti-sense oligonucleotide, compositions, kit and method for treatment of airway disorders associated with bronchoconstriction, lung inflammation,allergy(ies) and surfactant depletion
|
|
US7585847B2
(en)
*
|
2000-02-03 |
2009-09-08 |
Coley Pharmaceutical Group, Inc. |
Immunostimulatory nucleic acids for the treatment of asthma and allergy
|
|
CA2400573A1
(en)
*
|
2000-03-28 |
2001-10-04 |
Isis Pharmaceuticals Inc. |
Alteration of cellular behavior by antisense modulation of mrna processing
|
|
US8568766B2
(en)
|
2000-08-24 |
2013-10-29 |
Gattadahalli M. Anantharamaiah |
Peptides and peptide mimetics to treat pathologies associated with eye disease
|
|
JP5305553B2
(ja)
|
2000-10-12 |
2013-10-02 |
ユニバーシティー オブ ロチェスター |
癌細胞の増殖を阻害する組成物
|
|
EP2351765A3
(en)
*
|
2001-07-10 |
2012-02-22 |
Lakewood-Amedex, Inc |
Oligonucleotide-containing pharmacological compositions and their use
|
|
EP1572168B1
(en)
|
2002-02-06 |
2010-05-26 |
Vicor Technologies, Inc. |
Anti-infarction molecules
|
|
EP1534729A2
(en)
*
|
2002-02-26 |
2005-06-01 |
University of Utah Research Foundation |
Variants of nedd4l associated with hypertension and viral budding
|
|
US20050287648A1
(en)
|
2002-08-05 |
2005-12-29 |
University Of Rochester |
Protein Transducing Domain/Deaminase Chimeric Proteins, Related Compounds, and Uses Thereof
|
|
US7956043B2
(en)
*
|
2002-12-11 |
2011-06-07 |
Coley Pharmaceutical Group, Inc. |
5′ CpG nucleic acids and methods of use
|
|
EP1608403A2
(en)
*
|
2003-04-02 |
2005-12-28 |
Coley Pharmaceutical Group, Ltd. |
Immunostimulatory nucleic acid oil-in-water formulations for topical application
|
|
TWI235440B
(en)
*
|
2004-03-31 |
2005-07-01 |
Advanced Semiconductor Eng |
Method for making leadless semiconductor package
|
|
US8029815B2
(en)
*
|
2004-04-28 |
2011-10-04 |
Elford Howard L |
Methods for treating or preventing restenosis and other vascular proliferative disorders
|
|
US7968762B2
(en)
*
|
2004-07-13 |
2011-06-28 |
Van Andel Research Institute |
Immune-compromised transgenic mice expressing human hepatocyte growth factor (hHGF)
|
|
EP2551282A3
(en)
|
2005-03-23 |
2013-02-13 |
Genmab A/S |
Antibodies against CD38 for treatment of multiple myeloma
|
|
US7476733B2
(en)
*
|
2005-03-25 |
2009-01-13 |
The United States Of America As Represented By The Department Of Health And Human Services |
Development of a real-time PCR assay for detection of pneumococcal DNA and diagnosis of pneumococccal disease
|
|
EP1874325A2
(en)
*
|
2005-04-08 |
2008-01-09 |
Coley Pharmaceutical Group, Inc. |
Methods for treating infectious disease exacerbated asthma
|
|
EP2395076A1
(en)
|
2005-10-14 |
2011-12-14 |
MUSC Foundation For Research Development |
Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy
|
|
US8080534B2
(en)
|
2005-10-14 |
2011-12-20 |
Phigenix, Inc |
Targeting PAX2 for the treatment of breast cancer
|
|
EP2066812A4
(en)
|
2006-09-21 |
2010-04-28 |
Univ Rochester |
COMPOSITIONS AND METHODS RELATED TO PROTEIN SHIFT THERAPY FOR MYOTONE DYSTROPHY
|
|
WO2008136852A2
(en)
|
2006-11-01 |
2008-11-13 |
University Of Rochester |
Methods and compositions related to the structure and function of apobec3g
|
|
JP2010512327A
(ja)
*
|
2006-12-11 |
2010-04-22 |
ユニヴァーシティー オブ ユタ リサーチ ファウンデーション |
病的血管形成および脈管透過性の処置用の組成物および方法
|
|
US9526707B2
(en)
*
|
2007-08-13 |
2016-12-27 |
Howard L. Elford |
Methods for treating or preventing neuroinflammation or autoimmune diseases
|
|
AU2008296487A1
(en)
|
2007-08-28 |
2009-03-12 |
The Uab Research Foundation |
Synthetic apolipoprotein E mimicking polypeptides and methods of use
|
|
JP2010538005A
(ja)
|
2007-08-28 |
2010-12-09 |
ユーエービー リサーチ ファウンデーション |
合成アポリポ蛋白質ｅ模倣ポリペプチドおよび使用方法
|
|
WO2010070380A2
(en)
*
|
2007-12-03 |
2010-06-24 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health Of Human Services, National Institutes Of Health |
Doc1 compositions and methods for treating cancer
|
|
WO2009117418A2
(en)
*
|
2008-03-17 |
2009-09-24 |
The Board Of Regents Of The University Of Texas System |
Identification of micro-rnas involved in neuromuscular synapse maintenance and regeneration
|
|
US20110262395A1
(en)
|
2008-05-08 |
2011-10-27 |
University Of Utah Research Foundation |
Sensory receptors for chronic fatigue and pain and uses thereof
|
|
WO2010027641A2
(en)
*
|
2008-08-15 |
2010-03-11 |
Georgetown University |
Na channels, disease, and related assays and compositions
|
|
EP2350264A4
(en)
|
2008-11-06 |
2012-08-29 |
Univ Johns Hopkins |
TREATMENT OF CHRONIC INFLAMMATION OF THE RESPIRATORY TRACT
|
|
US20120070443A1
(en)
|
2008-12-02 |
2012-03-22 |
University Of Utah Research Foundation |
Pde1 as a target therapeutic in heart disease
|
|
WO2011031974A1
(en)
|
2009-09-10 |
2011-03-17 |
Southern Research Institute |
Acridine analogs in the treatment of gliomas
|
|
US20110207789A1
(en)
|
2010-02-19 |
2011-08-25 |
Ye Fang |
Methods related to casein kinase ii (ck2) inhibitors and the use of purinosome-disrupting ck2 inhibitors for anti-cancer therapy agents
|
|
EP2580243B1
(en)
|
2010-06-09 |
2019-10-16 |
Genmab A/S |
Antibodies against human cd38
|
|
JP5598510B2
(ja)
|
2012-08-28 |
2014-10-01 |
トヨタ自動車株式会社 |
内燃機関
|
|
WO2014093688A1
(en)
|
2012-12-12 |
2014-06-19 |
1Massachusetts Institute Of Technology |
Compositions and methods for functional nucleic acid delivery
|
|
EP3071590A4
(en)
|
2013-11-21 |
2017-07-19 |
SeNA Research, Inc. |
Methods for structural determination of selenium derivatized nucleic acid complexes
|
|
JP7081923B2
(ja)
|
2014-07-31 |
2022-06-07 |
ユーエイビー リサーチ ファンデーション |
アポｅ模倣ペプチド及び血漿コレステロールを取り除くためのより高い効果
|
|
SG11201900738YA
(en)
|
2016-07-28 |
2019-02-27 |
Regeneron Pharma |
Gpr156 variants and uses thereof
|
|
EP3496736A4
(en)
|
2016-08-03 |
2020-05-13 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
THERAPEUTICS AGAINST TLR9
|
|
CA3049980A1
(en)
|
2017-01-23 |
2018-07-26 |
Regeneron Pharmaceuticals, Inc. |
Hydroxysteroid 17-beta dehydrogenase 13 (hsd17b13) variants and uses thereof
|
|
DK3635102T3
(da)
|
2017-06-05 |
2025-10-27 |
Regeneron Pharma |
B4galt1-varianter og anvendelser deraf
|
|
CN111373053B
(zh)
|
2017-09-06 |
2024-07-30 |
雷杰纳荣制药公司 |
单免疫球蛋白白介素-1受体相关分子(sigirr)变体及其用途
|
|
SG11202001792UA
(en)
|
2017-09-07 |
2020-03-30 |
Regeneron Pharma |
Solute carrier family 14 member 1 (slc14a1) variants and uses thereof
|
|
WO2019051355A1
(en)
|
2017-09-08 |
2019-03-14 |
Ohio State Innovation Foundation |
NEW MICROARN INHIBITOR THERAPY FOR SYSTEMIC LUPUS ERYTHEMATOSUS
|
|
AU2018348195B2
(en)
|
2017-10-11 |
2025-05-15 |
Regeneron Pharmaceuticals, Inc. |
Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the PNPLA3 I148M variation
|
|
RU2020115869A
(ru)
|
2017-10-16 |
2021-11-19 |
Ридженерон Фармасьютикалз, Инк. |
Варианты корнулина (crnn) и их применение
|
|
MA56457A
(fr)
|
2019-07-02 |
2022-05-11 |
Regeneron Pharma |
Modulateurs de hsd17b13 et leurs procédés d'utilisation
|
|
WO2024173343A1
(en)
|
2023-02-14 |
2024-08-22 |
Regeneron Pharmaceuticals, Inc. |
Compounds targeting hydroxysteroid 17-beta dehydrogenase (hsd17b) and uses thereof
|